tiprankstipranks
Trending News
More News >
MediPharm Labs (MEDIF)
OTHER OTC:MEDIF
US Market
Advertisement

MediPharm Labs (MEDIF) Technical Analysis

Compare
413 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
3Neutral
3Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
MediPharm Labs’s (MEDIF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting MediPharm Labs is a Sell.
MediPharm Labs’s (MEDIF) 20-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Buy.
MediPharm Labs’s (MEDIF) 50-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Buy.

MediPharm Labs (MEDIF) Pivot Points

Aug 17, 2025, 07:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.04
0.05
0.05
0.06
0.07
0.07
0.08
Fibonacci
0.05
0.05
0.05
0.06
0.06
0.07
0.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MediPharm Labs (MEDIF) Moving Averages

Aug 17, 2025, 07:29 PM
Period
Simple
Exponential
MA5
0.06Buy
0.06Buy
MA10
0.05Buy
0.05Buy
MA20
0.05Buy
0.05Buy
MA50
0.05Buy
0.05Buy
MA100
0.06Buy
0.05Buy
MA200
0.05Buy
0.05Buy
MediPharm Labs’s (MEDIF) 10-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Buy.
MediPharm Labs’s (MEDIF) 100-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Buy.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 50-day simple moving average is 0.05, creating a Buy signal.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 100-day simple moving average is 0.06, creating a Buy signal.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 200-day simple moving average is 0.05, creating a Buy signal.

MediPharm Labs (MEDIF) Technical Indicators

Aug 17, 2025, 07:29 PM
Name
Value
Implied Action
RSI (14)
85.20
Sell
STOCH (9,6)
78.50
Neutral
STOCHRSI (14)
78.50
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
14.53
Buy
Williams %R
-22.73
Buy
CCI (14)
185.52
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
60.78
Neutral
ROC
20.00
Buy
MediPharm Labs’s (MEDIF) Relative Strength Index (RSI) is 85.20, creating a Sell signal.
MediPharm Labs’s (MEDIF) Trend Strength Indicator (ADX) is 14.53, creating a Buy signal.
MediPharm Labs’s (MEDIF) Commodity Channel Index (CCI) is 185.52, creating a Sell signal.
MediPharm Labs’s (MEDIF) Price Rate of Change (ROC) is 20.00, creating a Buy signal.

FAQ

Is MEDIF a Buy, Hold, or Sell?
Based on MEDIF’s technical indicators, MEDIF is a Strong Buy.
    What is MEDIF’s RSI (14)?
    MEDIF’s RSI (14) is 85.20, which suggests MEDIF is a Sell.
      What is MEDIF’s MACD?
      MEDIF’s MACD is <0.01, which suggests MEDIF is a Sell.
        What is MEDIF’s 5-day moving average?
        MEDIF’s 5-day moving average is 0.06, which suggests MEDIF is a Buy.
          What is MEDIF’s 20-day moving average?
          MEDIF 20-day moving average is 0.05, which suggests MEDIF is a Buy.
            What is MEDIF’s 50-day moving average?
            MEDIF’s 50-day moving average is 0.05, which suggests MEDIF is a Buy.
              What is MEDIF’s 200-day moving average?
              MEDIF’s 200-day moving average is 0.05, which suggests MEDIF is a Buy.
                What is MEDIF’s Williams % R (14)?
                MEDIF’s Williams % R (14) is -22.73, which suggests MEDIF is a Buy.
                  What is MEDIF’s CCI (14)?
                  MEDIF’s CCI (14) is 185.52, which suggests MEDIF is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis